The NTD has attracted much attention not only because of its known participation in transcriptional activity but also, and in particular, because diverse C-terminally truncated splice variants of AR lacking the LBD have been identified in prostate cancer cell lines and in clinical specimens [19]. This evidence concerns the gene AR and prostate carcinoma.